Evidence map›Paper›PMID 39290396›Full record

ArticleFrontiers in medicine2024

Deep learning infused SIRVD model for COVID-19 prediction: XGBoost-SIRVD-LSTM approach.

Hisham Alkhalefah, D Preethi, Neelu Khare, Mustufa Haider Abidi, Usama Umer

Abstract read
In one paragraph

Article in Frontiers in medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Hisham AlkhalefahAdvanced Manufacturing Institute, King Saud University, Riyadh, Saudi Arabia.
D PreethiDepartment of Computer Science and Engineering, Faculty of Engineering and Technology, SRM Institute of Science and Technology, Chennai, Tamil Nadu, India.
Neelu KhareSchool of Computer Science Engineering and Information Systems (SCORE), Vellore Institute of Technology, Vellore, Tamil Nadu, India.
Mustufa Haider AbidiAdvanced Manufacturing Institute, King Saud University, Riyadh, Saudi Arabia.
Usama UmerAdvanced Manufacturing Institute, King Saud University, Riyadh, Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The global impact of the ongoing COVID-19 pandemic, while somewhat contained, remains a critical challenge that has tested the resilience of humanity. Accurate and timely prediction of COVID-19 transmission dynamics and future trends is essential for informed decision-making in public health. Deep learning and mathematical models have emerged as promising tools, yet concerns regarding accuracy persist. This research suggests a novel model for forecasting the COVID-19's future trajectory. The model combines the benefits of machine learning models and mathematical models. The SIRVD model, a mathematical based model that depicts the reach of the infection via population, serves as basis for the proposed model. A deep prediction model for COVID-19 using XGBoost-SIRVD-LSTM is presented. The suggested approach combines Susceptible-Infected-Recovered-Vaccinated-Deceased (SIRVD), and a deep learning model, which includes Long Short-Term Memory (LSTM) and other prediction models, including feature selection using XGBoost method. The model keeps track of changes in each group's membership over time. To increase the SIRVD model's accuracy, machine learning is applied. The key properties for forecasting the spread of the infection are found using a method called feature selection. Then, in order to learn from these features and create predictions, a model involving deep learning is applied. The performance of the model proposed was assessed with prediction metrics such as

Indexed as

COVID-19deep learningextreme gradient boosting (XGBoost)feature selectionlong short-term memory (LSTM)predictionsusceptible-infected-recovered-vaccination-deceased (SIRVD)

Identifiers

PMID39290396
PMCPMC11405207

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.